May 19, 2026 04:14AM
May 5, 2026 04:05PM
Apr 27, 2026 07:45AM
Apr 27, 2026 07:45AM
Nov 5, 2025 04:05PM
Oct 3, 2025 08:05AM
Aug 5, 2025 04:05PM Jazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Jun 11, 2025 07:15AM
Jun 10, 2025 07:05AM
Jun 10, 2025 07:05AM
May 6, 2025 04:05PM
Apr 21, 2025 04:05PM
Apr 21, 2025 04:05PM
Mar 6, 2025 07:37AM Jazz Pharmaceuticals (JAZZ) PT Raised to $230 at Truist Following Chimerix Acquisition
Mar 5, 2025 07:02AM
Mar 5, 2025 07:00AM
Nov 21, 2024 07:46AM
Nov 6, 2024 04:05PM
Oct 23, 2024 06:54AM
Sep 16, 2024 07:30AM
Sep 16, 2024 07:30AM Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
Sep 11, 2024 07:11AM
Sep 9, 2024 07:58AM
Aug 1, 2024 06:26AM
Jul 31, 2024 04:05PM
Jun 5, 2024 02:23AM
Jun 1, 2024 08:05AM
May 29, 2024 02:21PM TD Cowen Reiterates Buy Rating on Jazz Pharmaceuticals (JAZZ)
May 29, 2024 07:45AM
May 29, 2024 07:45AM
May 7, 2024 04:00PM
Nov 8, 2023 04:01PM
Aug 8, 2023 04:01PM
Aug 3, 2021 04:05PM
Jun 25, 2021 07:45AM Jazz Pharmaceuticals (JAZZ) Announces Orphan Drug Exclusivity for Xywav Oral Solution
Jun 25, 2021 07:45AM
Jun 9, 2021 07:45AM
May 4, 2021 04:51PM
May 4, 2021 04:05PM
Apr 19, 2021 07:42AM
Apr 12, 2021 07:46AM
Apr 12, 2021 07:45AM Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Idiopathic Hyp
May 5, 2020 04:17PM
May 5, 2020 04:05PM
Mar 31, 2020 04:02PM
Mar 31, 2020 04:01PM
Mar 25, 2020 04:10PM
Mar 25, 2020 04:05PM
Feb 25, 2020 04:05PM Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2019 Financial Results
Feb 17, 2020 02:30AM

15,418 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All